EA5191: A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients with Previously Treated Non-Squamous NSCLC
This Study is
No Longer Enrolling
Adult
II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.
Treatment
Greeley Campus
Harmony Campus
Highlands Ranch Hospital
Medical Center of the Rockies
Poudre Valley Hospital
Protocol Number: 20-1737
More information available at ClinicalTrials.gov: NCT04310007
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers